Lead Product(s) : Multivalent Pneumococcal conjugate vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor :
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Details : Under an exclusive licensing agreement, Aeolian has been granted a license that includes compositions and methods of use of pneumococcal vaccines in the U.S. and Japan, and pending in other geographies.
Brand Name : iPCV22
Molecule Type : Vaccine
Upfront Cash : Undisclosed
January 30, 2023
Lead Product(s) : Multivalent Pneumococcal conjugate vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor :
Deal Size : Undisclosed
Deal Type : Licensing Agreement
LOOKING FOR A SUPPLIER?